Phytecs Phytecs develops products targeting the body's endocannabinoid system, a signaling network regulating aspects of physiology from emotion to motor function.

Phytecs focuses on products targeting the endocannabinoid system, which regulates nearly every process within our bodies from emotions to motor function.

12/24/2018

At this time of year marked by reflection, gratitude and sanctification, Phytecs extends its heartfelt appreciation to each and every collaborator and supporter from around the world who helped us take new and exciting steps on our strategic roadmap in 2018. May 2019 be a year of serenity, learning, mindfulness and growth in our personal lives, and continued investigation, discovery, fulfillment and success in our professional lives.

Phytecs President Gary Hiller is looking forward to joining global leaders in cannabinoid-biotech R&D at next week’s Int...
12/07/2018

Phytecs President Gary Hiller is looking forward to joining global leaders in cannabinoid-biotech R&D at next week’s International Cannabinoid Derived Pharmaceuticals Summit in Boston and to serving as conference Chair on Day 2 of the program.

A meeting dedicated to uniting industry and academia to pioneer the therapeutic use of cannabinoid APIs.

10/31/2018

At a recent Canadian Bar Association seminar, attorney Sara Zborovski (with Norton Rose Fulbright) urged the branding and marketing communities to collectively try to “get rid of the stigma and increase the credibility of this [cannabis] industry by not using silly words.” She correctly noted that “we don’t reference alcohol like ‘booze’ or ‘moonshine’ anymore,” and expressed her hope that “when we are talking publicly and about the industry. . . [that] we as an industry and as branding professionals will use [words such as] ‘cannabis’ and ‘ma*****na’ and not words such as ‘pot, dope, MJ, weed’.” She said, “let’s try to increase the level of discussion such that we can increase the credibility of the industry,” and added that she thinks this “will go a really long way towards protecting our kids.”

She is 100% correct and we encourage the branding community to apply her advice and suggestions. We do believe this should extend to other words such as indica, sativa and hybrid, since such terms have no actionable meaning to customers or relationship to outcomes and should not impact a purchase decision. Additionally, we hope that the branding and marketing communities encourage efforts to characterize cannabis products by their objective chemistries, which directly translate into effects. By focusing on properly characterized chemistries, the industry can explore the use of structure/function claims to educate consumers and distinguish products.

10/16/2018

In his presentation at CannX, Gary explored why positive anecdotal reports from patients on cannabis efficacy does not always align with negative published studies and explained how laboratory data could be used to inform and guide cannabis breeding work to increase efficacy.

10/15/2018

Phytecs President Gary Hiller is joining leaders in the medical cannabis field at CannX. Look for his presentation about the importance of developing and using cannabis plants that are targeted for indications in order to be therapeutically effective rather than using generic “cannabis.”

Phytecs President, Gary Hiller, will be attending and presenting at the   conference next week.  For those attending, lo...
10/12/2018

Phytecs President, Gary Hiller, will be attending and presenting at the conference next week. For those attending, looking forward to seeing you there!

If you want to be a leader in medical cannabis, join us in Tel Aviv, 14-16 October 2018!

In just a couple of hours Snowden Bishop will be joining leading researchers in the ECS field to talk about the latest r...
10/04/2018

In just a couple of hours Snowden Bishop will be joining leading researchers in the ECS field to talk about the latest research. Participation is free. Tune in at https://bit.ly/2xOPfHR

The DEA’s rescheduling of Epidiolex, a natural botanical medication derived from cannabis, is an historic development th...
10/03/2018

The DEA’s rescheduling of Epidiolex, a natural botanical medication derived from cannabis, is an historic development that we hope brings relief to patients suffering from intractable diseases. The FDA’s and DEA’s approach to Epidiolex encourages our view that the endocannabinoid system (ECS) is a critically-important drug target and that research and development into innovative means to modulate ECS function must continue.

This paves the way for GW Pharmaceuticals to start selling the first FDA-approved drug that's derived from cannabis, but the DEA stopped short of reclassifying all cannabidiol products.

With Corona investing over $4 billion in the cannabis industry and Coca-Cola reportedly eyeing the market as well, explo...
10/02/2018

With Corona investing over $4 billion in the cannabis industry and Coca-Cola reportedly eyeing the market as well, exploring cannabis research and better understanding the ECS is critical in advancing its therapeutic use. We’re bringing together experts to talk future innovation: https://bit.ly/2R14Yfx

Join the discussion! We are hosting a webinar, moderated by The Cannabis Reporter’s host Snowden Bishop to discuss emerg...
09/29/2018

Join the discussion! We are hosting a webinar, moderated by The Cannabis Reporter’s host Snowden Bishop to discuss emerging cannabis research and innovations. Participation is free and questions encouraged! Sign up at:

The cannabis industry is rapidly evolving in the United States and globally – just this month, Corona invested 4 billion dollars in a medical ma*****na company called Canopy Growth Corporation, and Coca-Cola is in talks with Aurora Cannabis on developing drinks infused with CBD. This evolution is ...

We're excited to announce our FREE webinar discussing the future of   and   research! It will be led by Snowden Bishop, ...
09/26/2018

We're excited to announce our FREE webinar discussing the future of and research! It will be led by Snowden Bishop, host of The Cannabis Reporter, featuring top cannabinoid researchers from around the world. Check out our event for details: https://bit.ly/2R14Yfx

Address

Los Angeles, CA
90067

Alerts

Be the first to know and let us send you an email when Phytecs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share